The future outlook for Centene Corporation (NYSE: CNC) is viewed by Wall Street analysts with a generally positive consensus, featuring a median 12-month price target sitting around $71 per share. Analysts highlight its strong positioning in government-sponsored healthcare programs, managed care efficiencies, and attractive valuation multiples relative to historical averages. However, future performance will depend heavily on navigating shifting healthcare policy regulations, medical loss ratio trends, and competitive managed care market dynamics.